Trial intelligence / Profile preview

Sandwich Chemoradiation in High-Risk Endometrial Cancer

NCT01041027Phase 2Terminated

Sponsor
Albert Einstein College of Medicine
Start
Jan 2009
Primary completion
Oct 2019
Modality
DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in endometrial cancer (EC), sponsored by Albert Einstein College of Medicine. Started Jan 2009; status: terminated.

02

Drugs

Paclitaxel Micelles for Injectioncarboplatin
03

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on NCT01041027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01041027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call